Patients treated with ≥10mg of prednisone were more likely to have brain metastasis and a worse performance status (ECOG PS ≥ 2) before immunotherapy. The researchers conclude that based on these data, corticosteroids should not necessarily be decreased or discontinued before the start of immunotherapy out of a theoretical concern that corticosteroids could impair a response to immunotherapy.